Immune checkpoint inhibitor-induced inflammatory arthritis persists after immunotherapy cessation

ICI-induced IA can become a long-term disease necessitating management by rheumatology for immunomodulatory treatment. Importantly, the use of immunomodulatory treatment has not been shown to impact cancer outcomes in this study.